| Date Filed | Type | Description |
| 01/27/2023 |
4
| Dorling Janet (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $7.8, valued at
$195k
|
|
| 01/27/2022 |
4
| Dorling Janet (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 67,000 options to buy
@ $2.94, valued at
$197k
|
|
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/25/2019 |
4
| Dorling Janet (Chief Commercial Officer) has filed a Form 4 on Achaogen, Inc.|
Txns:
| Sold 1,063 shares
@ $0.89, valued at
$946.1 |
|
| 02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| Dorling Janet (Chief Commercial Officer) has filed a Form 4 on Achaogen, Inc.|
Txns:
| Granted 187,800 shares
@ $0 |
|
| 01/23/2019 |
5
| Dorling Janet (Chief Commercial Officer) has filed a Form 5 on Achaogen, Inc. |
| 09/13/2018 |
4
| Dorling Janet (Chief Commercial Officer) has filed a Form 4 on Achaogen Inc|
Txns:
| Granted 80,000 options to buy
@ $4.79, valued at
$383.2k
|
|
| 06/28/2018 |
4
| Dorling Janet (Chief Commercial Officer) has filed a Form 4 on Achaogen Inc|
Txns:
| Granted 1,300 shares
@ $0
Sold 450 shares
@ $9.59, valued at
$4.3k
Granted 6,000 options to buy
@ $10.64, valued at
$63.8k
|
|
| 04/20/2018 |
3
| Dorling Janet (Chief Commercial Officer) has filed a Form 3 on Achaogen Inc |